查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1685167

血液气体和电解质分析仪市场机会、成长动力、产业趋势分析和预测 2025 - 2034

Blood Gas and Electrolyte Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球血气和电解质分析仪市场规模达到 19 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 5.2%。这一增长是由糖尿病、呼吸系统疾病、肾臟疾病和心血管疾病等慢性病的日益流行所推动的，所有这些疾病都需要频繁监测血气和电解质水平。医疗保健提供者越来越多地采用这些分析仪来确保准确、及时的诊断结果，从而改善重症监护环境中的患者治疗效果。对即时诊断解决方案不断增长的需求也在市场扩张中发挥了关键作用，医院、急诊和重症监护室 (ICU) 都依赖这些设备进行即时决策。

血气和电解质分析仪市场 - IMG1

技术的进步改变了血液气体和电解质测试格局，使其更加方便和高效。便携式和手持式分析仪的发展使得医疗保健专业人员能够在患者床边进行测试，最大限度地减少诊断和治疗的延误。此外，自动化和与电子健康记录 (EHR) 的整合简化了工作流程，减少了错误并提高了效率。对早期疾病检测和个人化医疗的日益重视进一步推动了对这些分析仪的需求，因为它们能够对重症患者进行持续监测和早期干预。此外，医疗保健基础设施投资的不断增长，加上全球人口老化，推动了先进诊断工具的采用，使得这个市场对製造商和利害关係人来说非常有利可图。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 19亿美元
预测值 31亿美元
复合年增长率 5.2％

市场分为便携式和桌上型分析仪，其中便携式设备预计将实现大幅成长。便携式市场预计将以 5.4% 的复合年增长率扩张，到 2034 年将达到 20 亿美元。这一增长主要得益于对即时诊断测试需求的不断增长，特别是在急诊室、ICU 和门诊护理设施中，快速准确的结果对于患者管理至关重要。便携式分析仪具有移动性、易用性和周转时间更快的优势，使临床医生无需进行集中实验室测试即可做出及时的决策。家庭医疗保健和远端病人监控的成长趋势进一步增加了对这些小型设备的需求，使得在传统医疗保健环境之外进行即时诊断成为可能。

就最终用途而言，市场涵盖即时检验、中央实验室、诊断中心、医院和其他医疗机构。由于重症监护环境中对快速、精确的诊断工具的迫切需求，即时诊断部分将在 2024 年占据 35.5% 的市场份额。这些分析仪在急诊室、手术室和重症监护室中发挥着至关重要的作用，即时的检测结果可以挽救生命。他们能够在患者床边提供即时见解，从而显着缩短週转时间、提高工作流程效率并确保及时介入。 POC 分析仪在门诊和家庭医疗保健环境中的广泛应用进一步巩固了其在市场中的地位。

2024 年美国血气和电解质分析仪市场规模达到 6.636 亿美元，预计 2025 年至 2034 年的复合年增长率为 5%。糖尿病、心血管疾病和呼吸系统疾病等慢性病发病率的增加是推动市场成长的主要因素。这些情况需要持续监测血液气体和电解质水平，从而推动对可靠、有效的诊断解决方案的需求。此外，美国老龄化人口面临更高的慢性和急性健康问题风险，导致医院、诊所和家庭医疗保健机构更多地采用这些分析仪。对基于价值的护理的日益关注，加上 POC 测试技术的进步，预计将进一步加速美国市场的扩张，使其成为行业参与者的主要收入来源。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 全球慢性病盛行率不断上升
      • 技术进步
      • 对整合系统的需求不断增加
    • 产业陷阱与挑战
      • 产品成本高
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 差距分析
  • 定价分析
  • 波特的分析
  • PESTEL 分析
  • 未来市场趋势

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按设备类型，2021 - 2034 年

  • 主要趋势
  • 便携的
  • 桌上型

第 6 章：市场估计与预测：按产品类型，2021 - 2034 年

  • 主要趋势
  • 耗材
  • 组合分析仪
  • 电解质分析仪
  • 血气分析仪

第 7 章：市场估计与预测：按最终用途，2021 - 2034 年

  • 主要趋势
  • 护理点
  • 中央实验室
  • 诊断中心
  • 医院
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • Abbott
  • Convergent Technologies
  • Cornley
  • EDAN
  • Erba Mannheim
  • Fortress Diagnostics
  • Medica
  • nova biomedical
  • OPTI Medical
  • RADIOMETER
  • Roche
  • SENSA CORE
  • SIEMENS Healthineers
  • Tecom
  • Werfen
简介目录
Product Code: 428

The Global Blood Gas And Electrolyte Analyzers Market reached USD 1.9 billion in 2024 and is projected to expand at a CAGR of 5.2% between 2025 and 2034. This growth is fueled by the increasing prevalence of chronic conditions such as diabetes, respiratory disorders, kidney diseases, and cardiovascular ailments, all of which require frequent monitoring of blood gas and electrolyte levels. Healthcare providers are increasingly adopting these analyzers to ensure precise and timely diagnostic results, improving patient outcomes in critical care settings. The rising demand for point-of-care (POC) diagnostic solutions has also played a key role in market expansion, with hospitals, emergency departments, and intensive care units (ICUs) relying on these devices for real-time decision-making.

Blood Gas and Electrolyte Analyzers Market - IMG1

Advancements in technology have transformed the blood gas and electrolyte testing landscape, making it more accessible and efficient. The development of portable and handheld analyzers has allowed healthcare professionals to conduct tests at the patient's bedside, minimizing delays in diagnosis and treatment. Additionally, automation and integration with electronic health records (EHRs) have streamlined workflows, reducing errors and improving efficiency. The increasing emphasis on early disease detection and personalized medicine is further driving the demand for these analyzers, as they enable continuous monitoring and early intervention in critically ill patients. Moreover, the growing investments in healthcare infrastructure, coupled with an aging global population, are pushing the adoption of advanced diagnostic tools, making this market highly lucrative for manufacturers and stakeholders.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 1.9 Billion
Forecast Value$ 3.1 Billion
CAGR5.2%

The market is segmented into portable and benchtop analyzers, with portable devices expected to see substantial growth. The portable segment is projected to expand at a CAGR of 5.4%, reaching USD 2 billion by 2034. This surge is primarily driven by the rising demand for point-of-care testing, particularly in emergency rooms, ICUs, and ambulatory care facilities, where rapid and accurate results are critical for patient management. Portable analyzers offer the advantage of mobility, ease of use, and faster turnaround times, allowing clinicians to make prompt decisions without the need for centralized laboratory testing. The growing trend of home healthcare and remote patient monitoring is further increasing the demand for these compact devices, enabling real-time diagnostics outside traditional healthcare settings.

In terms of end-use, the market spans point-of-care testing, central laboratories, diagnostic centers, hospitals, and other healthcare facilities. The point-of-care segment accounted for 35.5% of the market share in 2024, driven by the urgent need for fast and precise diagnostic tools in critical care settings. These analyzers play a crucial role in emergency rooms, operating rooms, and ICUs, where immediate test results can be life-saving. Their ability to deliver real-time insights at the patient's bedside significantly reduces turnaround time, improving workflow efficiency and ensuring timely interventions. The expanding use of POC analyzers in ambulatory care and home healthcare settings is further solidifying their position in the market.

The U.S. blood gas and electrolyte analyzers market reached USD 663.6 million in 2024, with an anticipated growth rate of 5% CAGR from 2025 to 2034. The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions is a major factor propelling market growth. These conditions require continuous monitoring of blood gas and electrolyte levels, driving demand for reliable and efficient diagnostic solutions. Additionally, the aging population in the U.S. faces a higher risk of both chronic and acute health issues, leading to greater adoption of these analyzers in hospitals, clinics, and home healthcare settings. The growing focus on value-based care, coupled with advancements in POC testing technologies, is expected to further accelerate the expansion of the U.S. market, making it a key revenue generator for industry players.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic disease worldwide
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Increasing demand for integrated system
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with product
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Pricing analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Portable
  • 5.3 Benchtop

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Consumables
  • 6.3 Combined analyzers
  • 6.4 Electrolyte analyzers
  • 6.5 Blood gas analyzers

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Point-of-care
  • 7.3 Central laboratories
  • 7.4 Diagnostic centers
  • 7.5 Hospitals
  • 7.6 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Convergent Technologies
  • 9.3 Cornley
  • 9.4 EDAN
  • 9.5 Erba Mannheim
  • 9.6 Fortress Diagnostics
  • 9.7 Medica
  • 9.8 nova biomedical
  • 9.9 OPTI Medical
  • 9.10 RADIOMETER
  • 9.11 Roche
  • 9.12 SENSA CORE
  • 9.13 SIEMENS Healthineers
  • 9.14 Tecom
  • 9.15 Werfen